Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,146

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

Open access
Lalu, Manoj M., McIntyre, Lauralyn, Pugliese, Christina, Fergusson, Dean, Winston, Brent W., Marshall, John C., Granton, John, Stewart, Duncan J., Canadian Critical Care Trials Group · 2012 · PLoS ONE

Abstract

BACKGROUND: Mesenchymal stromal cells (MSCs, "adult stem cells") have been widely used experimentally in a variety of clinical contexts. There is interest in using these cells in critical illness, however, the safety profile of these cells is not well known. We thus conducted a systematic review of clinical trials that examined the use MSCs to evaluate their safety. METHODS AND FINDINGS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (to June 2011), were searched. Prospective clinical trials that used intravascular delivery of MSCs (intravenously or intra-arterially) in adult populations or mixed adult and pediatric populations were identified. Studies using differentiated MSCs or additional cell types were excluded. The primary outcome adverse events were grouped according to immediate events (acute infusional toxicity, fever), organ system complications, infection, and longer term adverse events (death, malignancy). 2347 citations were reviewed and 36 studies met inclusion criteria. A total of 1012 participants with clinical conditions of ischemic stroke, Crohn's disease, cardiomyopathy, myocardial infarction, graft versus host disease, and healthy volunteers were included. Eight studies were randomized control trials (RCTs) and enrolled 321 participants. Meta-analysis of the RCTs did not detect an association between acute infusional toxicity, organ system complications, infection, death or malignancy. There was a significant association between MSCs and transient fever. CONCLUSIONS: Based on the current clinical trials, MSC therapy appears safe. However, further larger scale controlled clinical trials with rigorous reporting of adverse events are required to further define the safety profile of MSCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0047559

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 7

  1. (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5, The Cochrane Library. In: Higgins JPT, Green S, editors. Chichester, UK: John Wiley & Sons, Ltd.
  2. S Chen, 2006, Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery, J Invasive Cardiol, 18, 552
  3. JA Wang, 2006, [A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy], Zhonghua Xin Xue Guan Bing Za Zhi, 34, 107
  4. ZW Xie, 2007, Curative effect of autologous mesenchymal stem cell transplantation on spinal cord injury. [Chinese], Journal of Clinical Rehabilitative Tissue Engineering Research, 11, 1277
  5. Z Yang, 2010, A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery, Cardiovasc Ther, 28, 380, 10.1111/j.1755-5922.2009.00116.x · doi:10.1111/j.1755-5922.2009.00116.x
  6. X Zhang, 2010, Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases, Int J Lab Hematol, 32, 256, 10.1111/j.1751-553X.2009.01181.x · doi:10.1111/j.1751-553x.2009.01181.x
  7. R Syme, 2004, The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity, Biol Blood Marrow Transplant, 10, 135, 10.1016/j.bbmt.2003.09.016 · doi:10.1016/j.bbmt.2003.09.016

Cited by

See all 1,146

Metadata

Authors
Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., Granton, J., Stewart, D. J., & Canadian Critical Care Trials Group
Venue
PLoS ONE
Published
2012-10-25
Volume
7
Issue
10
Pages
e47559
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2031790029
Cited by
1,146
References
51
FWCI
6.82
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.